As of 2025-05-23, the EV/EBITDA ratio of Affimed NV (AFMD) is -0.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AFMD's latest enterprise value is 7.42 mil USD. AFMD's TTM EBITDA according to its financial statements is -61.80 mil USD. Dividing these 2 quantities gives us the above AFMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.1x - 2.5x | 2.3x |
| Forward P/E multiples | 1.4x - 2.3x | 1.8x |
| Fair Price | (21.34) - (23.08) | (20.91) |
| Upside | -11859.0% - -12817.3% | -11619.4% |
| Date | EV/EBITDA |
| 2025-05-21 | -0.09 |
| 2025-05-20 | -0.10 |
| 2025-05-19 | -0.11 |
| 2025-05-16 | -0.12 |
| 2025-05-15 | -0.10 |
| 2025-05-14 | -0.10 |
| 2025-05-13 | -0.10 |
| 2025-05-12 | -0.16 |
| 2025-05-09 | -0.16 |
| 2025-05-08 | -0.16 |
| 2025-05-07 | -0.16 |
| 2025-05-06 | -0.17 |
| 2025-05-05 | -0.17 |
| 2025-05-02 | -0.19 |
| 2025-05-01 | -0.20 |
| 2025-04-30 | -0.19 |
| 2025-04-29 | -0.19 |
| 2025-04-28 | -0.19 |
| 2025-04-25 | -0.19 |
| 2025-04-24 | -0.18 |
| 2025-04-23 | -0.17 |
| 2025-04-22 | -0.17 |
| 2025-04-21 | -0.16 |
| 2025-04-17 | -0.16 |
| 2025-04-16 | -0.16 |
| 2025-04-15 | -0.16 |
| 2025-04-14 | -0.17 |
| 2025-04-11 | -0.15 |
| 2025-04-10 | -0.15 |
| 2025-04-09 | -0.15 |
| 2025-04-08 | -0.15 |
| 2025-04-07 | -0.15 |
| 2025-04-04 | -0.15 |
| 2025-04-03 | -0.15 |
| 2025-04-02 | -0.16 |
| 2025-04-01 | -0.16 |
| 2025-03-31 | -0.16 |
| 2025-03-28 | -0.17 |
| 2025-03-27 | -0.17 |
| 2025-03-26 | -0.17 |
| 2025-03-25 | -0.18 |
| 2025-03-24 | -0.18 |
| 2025-03-21 | -0.18 |
| 2025-03-20 | -0.18 |
| 2025-03-19 | -0.18 |
| 2025-03-18 | -0.18 |
| 2025-03-17 | -0.18 |
| 2025-03-14 | -0.18 |
| 2025-03-13 | -0.18 |
| 2025-03-12 | -0.18 |